"Risk Assessment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
| Descriptor ID |
D018570
|
| MeSH Number(s) |
E05.318.740.600.800.715 N04.452.871.715 N05.715.360.750.625.700.690 N06.850.505.715 N06.850.520.830.600.800.715
|
| Concept/Terms |
Risk Assessment- Risk Assessment
- Assessments, Risk
- Risk Assessments
- Health Risk Assessment
- Assessment, Health Risk
- Assessments, Health Risk
- Health Risk Assessments
- Risk Assessment, Health
- Risk Assessments, Health
- Assessment, Risk
Benefit-Risk Assessment- Benefit-Risk Assessment
- Assessment, Benefit-Risk
- Assessments, Benefit-Risk
- Benefit Risk Assessment
- Benefit-Risk Assessments
- Risk-Benefit Assessment
- Assessment, Risk-Benefit
- Assessments, Risk-Benefit
- Risk Benefit Assessment
- Risk-Benefit Assessments
|
Below are MeSH descriptors whose meaning is more general than "Risk Assessment".
Below are MeSH descriptors whose meaning is more specific than "Risk Assessment".
This graph shows the total number of publications written about "Risk Assessment" by people in this website by year, and whether "Risk Assessment" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 5 | 6 |
| 1997 | 2 | 5 | 7 |
| 1998 | 0 | 4 | 4 |
| 1999 | 1 | 1 | 2 |
| 2000 | 0 | 12 | 12 |
| 2001 | 1 | 22 | 23 |
| 2002 | 0 | 33 | 33 |
| 2003 | 2 | 50 | 52 |
| 2004 | 4 | 56 | 60 |
| 2005 | 2 | 57 | 59 |
| 2006 | 7 | 41 | 48 |
| 2007 | 10 | 64 | 74 |
| 2008 | 2 | 80 | 82 |
| 2009 | 6 | 83 | 89 |
| 2010 | 6 | 94 | 100 |
| 2011 | 3 | 146 | 149 |
| 2012 | 6 | 119 | 125 |
| 2013 | 6 | 114 | 120 |
| 2014 | 19 | 122 | 141 |
| 2015 | 19 | 110 | 129 |
| 2016 | 15 | 138 | 153 |
| 2017 | 21 | 152 | 173 |
| 2018 | 18 | 153 | 171 |
| 2019 | 31 | 156 | 187 |
| 2020 | 22 | 152 | 174 |
| 2021 | 16 | 107 | 123 |
| 2022 | 0 | 44 | 44 |
| 2023 | 0 | 54 | 54 |
| 2024 | 1 | 121 | 122 |
| 2025 | 0 | 124 | 124 |
| 2026 | 0 | 66 | 66 |
To return to the timeline,
click here.
Below are the most recent publications written about "Risk Assessment" by people in Profiles.
-
Predicting the Path to Attrition: Multidomain Risk Assessment in Diabetic Foot Ulcer Offloading Randomized Controlled Trials. Diabetes Care. 2026 Sep 01; 49(9):1681-1685.
-
Heuriskance: a novel paradigm for systematic earlier detection of sporadic pancreatic cancer. J Natl Cancer Inst. 2026 Aug 01; 118(8):1353-1363.
-
Comprehensive Evaluation of Atherosclerotic Cardiovascular Disease Risk Predictors Across the Pooled Cohort Equations, Predicting Risk of Cardiovascular Disease Events, and an Expanded Model. J Am Heart Assoc. 2026 Aug 04; 15(15):e049726.
-
Biomarker-Based Eligibility for Lung Cancer Screening: Validation of the Protein-Based INTEGRAL-Risk Model. JAMA. 2026 Jul 28; 336(4):323-333.
-
Global multicenter validation of noninvasive fibrosis assessment pathways in MetALD and ALD. Hepatol Commun. 2026 Aug 01; 10(8).
-
Revised Thyroid Differentiation Score for Risk Stratification in Papillary Thyroid Carcinoma. JCO Precis Oncol. 2026 Jul; 10(7):e2600207.
-
Time to Personalize Surveillance for Cancer Therapy-Related Cardiac Dysfunction in HER2-Targeted Therapy: One Size Does Not Fit All. Curr Heart Fail Rep. 2026 Jul 22; 23(1).
-
Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions. Liver Int. 2026 07; 46(7):e70734.
-
Redo-TAVR (TAV-in-TAV) Best Practices Part 1: Short-in-Short and Short-in-Tall: A Heart and Valve Collaboratory Document. JACC Cardiovasc Interv. 2026 08 10; 19(15):1999-2024.
-
Biallelic ARID1A Alterations : A Promising Novel Biomarker for Risk Stratification and Management in Pediatric Malignant Hepatocellular Tumors. Am J Surg Pathol. 2026 Sep 01; 50(9):1106-1119.